ERYTECH to Present at Cowen & Company 39th Annual Healthcare Conference Meeting

NEXT STORY
Darolutamide submitted for European marketing authorization
PREV STORY
Sanofi: FDA to undertake priority review of Dupixent® (dupilumab) for adults with inadequately controlled severe chronic rhinosinusitis with nasal polyps
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

DSS BioHealth Security, Inc. Announces the Addition of Mr. Daryl Thompson and Dr. Roscoe Moore to Advisory Team

author_avatar
NASDAQ Market News

Paratek Pharmaceuticals to Report First Quarter 2018 Financial Results on May 9, 2018

author_avatar
NASDAQ Market News

Mereo BioPharma to Present at the Stifel 2020 Virtual Healthcare Conference

author_avatar
NASDAQ Market News